Answers are grounded in this paper and cite their sources.
Objectives: To evaluate patient-reported satisfaction, usability and acceptability of EvoCheck Premium LinX Continuous Glucose Monitoring (CGM) system among adults with diabetes, and to describe changes in mean glucose.Methodology: This prospective, single-arm study included 848 adults with Type-1 or Type-2 diabetes using a real-time CGM system (EvoCheck Premium Linx (GX-01S)) in routine clinical care in Pakistan from April to June 2026. Participants received structured education about usage of CGM with a trained Diabetic Educator. Follow-up assessments were conducted on Days seven and 14. Satisfaction was assessed using five-point Likert-scale items; mean sensor glucose was compared between Day one and Day 14.Results: Mean overall-satisfaction rating was 4.84 ± 0.51. Mean item ratings ranged from 4.94 to 4.98 for exercise guidance, meal planning, glucose interpretation, alarm usefulness and trend understanding. Mean sensor glucose decreased from 168.92 to 146.65 mg/dL (absolute reduction 22.27 mg/dL; 13.2%).Conclusion: Use of EvoCheck Premium LinX CGM was associated with high patient satisfaction, favorable perceptions of usability and acceptability, and a reduction in mean sensor glucose. These findings support its effective utility in routine diabetes care when accompanied by structured patient education.
No takes yet. Share an insight, caveat, or question.
Jawaid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: